Antagonizing the alpha 4 beta 1 Integrin, but Not alpha 4 beta 7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis

The immune system is characterized by the preferential migration of lymphocytes through specific tissues (i.e., tissue tropism). Tissue tropism is mediated, in part, by the alpha 4 integrins expressed by T lymphocytes. The alpha 4 beta 1 integrin mediates migration of memory T lymphocytes into the C...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 190; no. 5; pp. 1961 - 1973
Main Authors Haanstra, Krista G, Hofman, Sam O, Lopes Estevao, Dave M, Blezer, Erwin LA, Bauer, Jan, Yang, Li-Li, Wyant, Tim, Csizmadia, Vilmos, 't Hart, Bert A, Fedyk, Eric R
Format Journal Article
LanguageEnglish
Published 01.03.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The immune system is characterized by the preferential migration of lymphocytes through specific tissues (i.e., tissue tropism). Tissue tropism is mediated, in part, by the alpha 4 integrins expressed by T lymphocytes. The alpha 4 beta 1 integrin mediates migration of memory T lymphocytes into the CNS, whereas the alpha 4 beta 7 integrin mediates migration preferentially into gastrointestinal tissue. This paradigm was established primarily from investigations in rodents; thus, the objective of this investigation was to determine if blocking the alpha 4 beta 7 integrin exclusively would affect migration of T lymphocytes into the CNS of primates. The effects of the dual alpha 4 beta 1 and alpha 4 beta 7 antagonist natalizumab were compared with those of the alpha 4 beta 7 antagonist vedolizumab on experimental autoimmune encephalomyelitis in the rhesus monkey. Animals received an initial i.v. bolus of placebo, natalizumab (30 mg/kg), or vedolizumab (30 mg/kg) before intracutaneous immunization with recombinant human myelin oligodendrocyte glycoprotein and then Ab once weekly thereafter. Natalizumab prevented CNS inflammation and demyelination significantly (p < 0.05), compared with time-matched placebo control animals, whereas vedolizumab did not inhibit these effects, despite saturating the alpha 4 beta 7 integrin in each animal for the duration of the investigation. These results demonstrate that blocking alpha 4 beta 7 exclusively does not inhibit immune surveillance of the CNS in primates.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-2
ISSN:0022-1767
DOI:10.4049/jimmunol.1202490